Gene therapy in neuromuscular and mitochondrial disorders

11 May 2021

‘Gene therapy in neuromuscular and mitochondrial disorders’​ by Thomas Klopstock on May 11, 2021 03:00 PM CET

The speaker is Professor of Neurology at the Ludwig Maximilans University in Munich. His clinical and scientific interests include rare mitochondrial diseases, the disease group “Neurodegeneration with Brain Iron Accumulation” (NBIA) and other neurogenetic disorders.

This is a ERN-RND webinar. Educational webinars on RARE neurological, neuromuscular and movement disorders and on advanced therapies jointly organized by the European Reference Networks for Rare Neurological Diseases (ERN-RND) and Neuromuscular Diseases (ERN EuroNMD) and the European Academy of Neurology (EAN).

 

 

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern